SC 13G
SC 13G
- Company
- AYTU BIOPHARMA, INC
- Filed
- August 15, 2022
- Accession Number
- 0001104659-22-090782
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →